Epimedin B
Epimedin B is a bioactive small molecule studied for its potential anti-osteoporotic effects, primarily through the stimulation of osteoblast activity. Research applications include in vitro assays for bone formation mechanisms and in vivo models investigating bone density and microstructure.
Product Specifications
CAS Number
110623-73-9
Product Name Alternative
Inhibitor, Epimedin B, Epmedin B, inhibit
Purity
99.67% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween-80+45% Saline:0.5 mg/mL (0.62 mM) ; DMSO:11 mg/mL (13.6 mM)
Smiles
[H][C@@]1 (O[C@@H]2[C@H] (O) [C@@H] (O) [C@H] (C) O[C@H]2Oc2c (oc3c (CC=C (C) C) c (O[C@@H]4O[C@H] (CO) [C@@H] (O) [C@H] (O) [C@H]4O) cc (O) c3c2=O) -c2ccc (OC) cc2) OC[C@@H] (O) [C@H] (O) [C@H]1O
Molecular Formula
C38H48O19
Molecular Weight
808.78
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PTX22747 100 µg
Anti-Human CSPG4/HMW-MAA/MCSP/NG2 Monoclonal Antibody (9.2.27#), APC
Sign In for Pricing
View Details 